This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
"Reserpine in the Treatment of Neuropsychiatric, Neurological, and Related Clinical Problems" is the subject of the April 15, 1955, issue of the Annals of the New York Academy of Sciences. Thirty papers describe the neuropharmacology and clinical uses of the drug. Two of the papers report the use of chloropromazine as well as the use of reserpine. The papers were the result of a conference on reserpine held by the Section of Biology of the New York Academy of Sciences on Feb. 3 and 4, 1955. Included are reports on the use of reserpine in the various psychoses and neuroses, ambulatory and hospitalized geriatric psychotics, essential hypertension, chronic schizophrenic reactions, shock-reversible and shock-resistent patients, chronically disturbed psychotic patients; irritable and hypertonic infants; office and private psychiatric practice; organic convulsive states, enuresis, and head injuries; epilepsy and behavior problems in children; narcotic withdrawal sickness; dermatological therapy; preoperative, peroperative, and postoperative sedation;
Spriegel WB. Reserpine in the Treatment of Neuropsychiatric, Neurological, and Related Clinical Problems. AMA Arch Intern Med. 1955;96(3):434–435. doi:10.1001/archinte.1955.00250140156024
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: